# reload+after+2024-01-20 02:44:17.716060
address1§3240 Bayshore Boulevard
city§Brisbane
state§CA
zip§94005
country§United States
phone§415 657 5500
website§https://www.cutera.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
fullTimeEmployees§540
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Michael A. Karavitis Ph.D.', 'age': 53, 'title': 'Executive VP & Chief Technology Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 595796, 'exercisedValue': 0, 'unexercisedValue': 40781}, {'maxAge': 1, 'name': 'Mr. Taylor C. Harris', 'age': 47, 'title': 'President, CEO & Director', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Stuart  Drummond', 'title': 'Interim Chief Financial Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeffrey S. Jones', 'age': 67, 'title': 'Chief Operating Officer', 'yearBorn': 1956, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Charles G. Thier', 'age': 60, 'title': 'Chief Information Officer', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 620842, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Anne  Werdan', 'title': 'Director of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Stephana E. Patton J.D., Ph.D.', 'age': 52, 'title': 'Chief Legal Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Steve  Kreider', 'title': 'Senior Vice President of Global Marketing', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Brent  Hauser', 'age': 46, 'title': 'President of International', 'yearBorn': 1977, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§10
compensationRisk§4
shareHolderRightsRisk§4
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.672
priceToSalesTrailing12Months§0.24615522
currency§USD
dateShortInterest§1702598400
forwardEps§-2.99
pegRatio§-0.04
exchange§NMS
quoteType§EQUITY
shortName§Cutera, Inc.
longName§Cutera, Inc.
firstTradeDateEpochUtc§1080743400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§44b7311f-f004-301d-a79d-f4f930c5bede
gmtOffSetMilliseconds§-18000000
targetHighPrice§10.0
targetLowPrice§3.0
targetMeanPrice§7.67
targetMedianPrice§10.0
recommendationMean§2.7
recommendationKey§hold
numberOfAnalystOpinions§3
quickRatio§2.768
grossMargins§0.51133
ebitdaMargins§-0.22501
trailingPegRatio§None
